A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Conditions
Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, Anniston, Alabama, United States
Research Site, Birmingham, Alabama, United States
Research Site, La Jolla, California, United States
Research Site, Sacramento, California, United States
Research Site, Iowa City, Iowa, United States
Research Site, Omaha, Nebraska, United States
Research Site, Chapel Hill, North Carolina, United States
Research Site, Hamilton, Ontario, Canada
Research Site, Sherbrooke, Quebec, Canada
Research Site, Beijing, China
Research Site, Shanghai, China
Research Site, Wuhan, China
Research Site, Zhengzhou, China
Research Site, Bordeaux, France
Research Site, Montpellier, France
Research Site, Nancy, France
Research Site, Paris, France
Research Site, Strasbourg, France
Research Site, Toulouse, France
Research Site, Cologne, Germany
Research Site, Erlangen, Germany
Research Site, Magdeburg, Germany
Research Site, Pok Fu Lam, Hong Kong
Research Site, Bunkyō City, Japan
Research Site, Kita-gun, Japan
Research Site, Kitakyushu-shi, Japan
Research Site, Kyoto, Japan
Research Site, Nagasaki, Japan
Research Site, Amsterdam, Netherlands
Research Site, Leiden, Netherlands
Research Site, Mérida, Spain
Research Site, Seville, Spain
Research Site, Valladolid, Spain
Research Site, Glasgow, United Kingdom
Research Site, London, United Kingdom
Research Site, London, United Kingdom
Research Site, Southampton, United Kingdom